EMEA-001667-PIP01-14
Key facts
Active substance |
abaloparatide
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/0307/2014
|
PIP number |
EMEA-001667-PIP01-14
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of osteoporosis
|
Route(s) of administration |
|
Contact for public enquiries |
Triskel EU Services, Ltd (Jean-Yves le Cotonnec)
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|